Merck Receivables 2010-2024 | MRK

Merck receivables for the quarter ending December 31, 2024 were $10.278B, a 0.69% decline year-over-year.

  • Merck receivables for 2024 were $10.278B, a 0.69% decline from 2023.
  • Merck receivables for 2023 were $10.349B, a 9.51% increase from 2022.
  • Merck receivables for 2022 were $9.45B, a 2.38% increase from 2021.

Merck Receivables 2010-2024 | MRK

  • Merck receivables for 2024 were $10.278B, a 0.69% decline from 2023.
  • Merck receivables for 2023 were $10.349B, a 9.51% increase from 2022.
  • Merck receivables for 2022 were $9.45B, a 2.38% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B